Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just bought another 2,000 shares at 1.91
Volume should pick up as we get closer to June.
This one is definitely testing my patience.
Looks like Sheff is in here now with us.
Should move up nicely into ASCO meeting
CRMMF
CRH Medical management has been pushing all the right buttons.
Financials continue to impress.
IMO, it's only a matter of time for this to show up on the mainstream radar, and then it should fly.
HRTX
Primed for data release on June 1 at ASCO in Chicago followed by CEO presentation in New York on June 2.
Looking for this to run a bit into those dates.
Multiple posters will be presented in Chicago on June 1 and then
Monday, June 2 in New York we will hear further data from CEO.
Should be good enough catalysts for the next few days IMO
Great idea!!
The SP bounced right back up to where Sheff sold yesterday, even with the overall negative market pressure.
We should continue to move up past $2 IMO
No
He just has a large following that echo his trades.
It only briefly affects the SP.
I'm in here at $1.36
Pipeline looks good.
That's correct. We should move up nicely into the June 17 ADCOM meeting.
Sheff effect hurt us here today.
He bailed at 1.90 and the stock slid immediately.
I took the opportunity to buy more at 1.79
Re-entered here today at 11.183
ACAD..
Acadia Pharmaceuticals Bullish Stance Reiterated at Needham & Company Post Q1
http://t.co/CzZWWHq8HW
CPRX should be primed and ready for a nice run.
Yep
Almost all were sell orders!
The filing is for shelf $.
It doesn't mean they have to use it.
The market understands that this has a huge potential upside over the next few weeks headed into FDA decision!
Yep
I have a fever and the medicine is some positive news from corporate .
Lol!
Yes
Then you get a 21% price drop in one day!
You have to address shareholders or your stock goes lower than whale dung!
Nice move up here today! Consolidation sub-20 is a good sign for the next run up IMO
I agree with you but I think the short-term move up is higher than $71
Looking for a solid bounce here in the next few weeks.
GLTA
It does get to be like a bad addiction.
It's just that we know the potential is there!
I don't think that smell is coffee?
Just saying...
Might buy now?
Between ETRM and CPRX I am getting killed!
Seems way undervalued here?
I just bought more.
Looking forward to the run up.
Continued silence from corporate will only allow this to naturally decay back to the .50's
We need positive press releases to push us upward.
Just picked up a big chunk at 1.89
IMO
She drops tomorrow
Possible buying opportunity in high 1.40's ?
ACAD
Chart looks good here IMO
I sold my XIV and covered my TVIX on Friday.
Looking for a quick drop this AM also to get back into XIV at some point today.
I sold most at 2.94 before results last Friday.
Then bought back in at 1.66 but only a small position. I had made good profits flipping it 3 times before.
I was lucky to only lose $550 total on that last flip.
IMO a 10% move up from the current share price is very possible in the near term.
I bought in yesterday at 70.38
I have it on a very short leash tho
GLTA
I sold all for a small loss.
I'm out if this one for keeps. I don't like the misleading way that management released the results.
Or "C", they font care about their stock price.
Looks like they did not enroll sufficient patients to get the power that they needed to separate from just the trend statement.
Bottom line though, if I'm the patient, I want to be in the combo treatment arm.
I think it goes to the low 1.50's to high 1.40's
But you are correct in thinking that the drop may already be baked in.
I'm watching it closely for a possible entry after financial.
I was in NAVB for a very long time.
The quarter financials have historically disappointed and I don't think that Lymphoseek sales will give the quarter a boost.
NAVB typically sells off after financials are reported.
I was just thinking that if the sp falls, I pick up some shares for a bounce play.
Good luck to you. I respect your picks!
I agree
Either the p value is less than 1 or it's not.
Just spell it out.
In the end, I think it's a positive study but the incompetence in reporting the results led to a panic.
Hopefully, it will bounce after we get clarity that favors our long position!
Was it the p value?
The numbers were good at 12 and 24 months.
The trend stayed on the treatment side (combo tx) all along.
If I'm the patient, I would want the combo.
Safety was established.
Looks good to me.